Canada Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
TerrAscend Corp (TSNDF) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Expansion Amidst Market Challenges
TerrAscend Corp (TSNDF) reports a 7.5% revenue increase and strategic growth plans, despite retail revenue decline and market pressures. Oct 09, 2024
GuruFocus News Drug Manufacturers
Cronos Group Inc (CRON) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion Amid Market Challenges
Cronos Group Inc (CRON) reports a 46% revenue increase and strategic investments in GrowCo, while navigating operational and regulatory hurdles. Oct 09, 2024
GuruFocus News Drug Manufacturers
HLS Therapeutics Inc (HLTRF) Q2 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges
Despite a dip in total revenue, HLS Therapeutics Inc (HLTRF) showcases robust growth in key product lines and strategic financial maneuvers to strengthen its market position. Oct 09, 2024
GuruFocus News Drug Manufacturers
Knight Therapeutics Inc (KHTRF) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic Pipeline Expansion
Knight Therapeutics Inc (KHTRF) reports robust growth in oncology and specialty portfolios, while navigating challenges in infectious disease revenue and operational expenses. Oct 09, 2024
GuruFocus News Drug Manufacturers
Bausch Health Companies Inc (BHC) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Changes
Bausch Health Companies Inc (BHC) reports its fifth consecutive quarter of growth, driven by strategic leadership changes and robust performance in key segments. Oct 09, 2024
GuruFocus News Drug Manufacturers
Delivra Health Brands Inc (DHBUF) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Financial Health Secured
Delivra Health Brands Inc (DHBUF) reports a 26% revenue increase and eliminates cash burn, setting the stage for future expansion. Oct 09, 2024